www.hczq.com 证券研究报告 化妆品行业跟踪：林清轩通过港交所聆讯 2025年12月29日 分析师 汤秀洁 执业编号：S0360525080008 邮箱：tangxiujie@hcyjs.com 联系人 王笑飞 执业编号：S0360125090005 邮箱：wangxiaofei@hcyjs.com 本报告由华创证券有限责任公司编制 。本公司不会因接收人收到本报告而视其为客户。华创证券对这些信息的准确性和完整性不作任何保证。报告中的内容和意见仅供参考， 并不构成本公司对所述证券买卖的出价或询价。本报告所载信息均为个人观点，并不构成对所涉及证券的个人投资建议。 请仔细阅读PPT后部分的分析师声明及免责声明。 @2021 华创 版权所有 摘要 证券研究报告 此页包含机密资料，其全部或任何部分不可被复制或再发送。本页不构成对任何产品的要约出售/购买、招揽或建议。关于免责声明全文，详见本PPT最后部分。 2 林清轩：甄选高山红山茶花，开创以油养肤理念，连续11年位居精华油榜首，线下554家门店并逐步发力电商，精耕细作铸就国货高端品牌。 行业：预测2025年以油养肤市场规模从2024年77亿元同比增长45%至 ...

Investment Rating - The investment rating for the industry is "Outperform the Market" [2][3] Core Insights - The beauty industry has entered a stable growth phase, with increasing consumer demand differentiation and intensified competition, necessitating higher operational standards for brand management [4][65] - Domestic brands, including Lin Qingxuan, have made significant progress in the high-end market, leveraging unique Chinese ingredients to create differentiated products and enhancing brand value through effective channel strategies [4][65] - Lin Qingxuan is positioned as a leading domestic high-end skincare brand, ranking 13th among all high-end skincare brands in China with a market share of 1.4% [5][26] Company Overview - Lin Qingxuan plans to officially list on the Hong Kong Stock Exchange on December 30, issuing approximately 13.97 million H shares at an offering price of HKD 77.77 per share, aiming to raise around HKD 1.086 billion [4] - The company has established a full industry chain from raw material planting to R&D, production, and sales, focusing on its core product, the Camellia Oil, which has been a market leader for 11 consecutive years [5][6] Financial Performance - In 2024, Lin Qingxuan is projected to achieve revenue of CNY 1.21 billion, a year-on-year increase of 50.27%, and a net profit of CNY 187 million, up 121.06% [15] - The company has maintained rapid revenue growth over the past three years, with a significant increase in profit margins, indicating strong operational efficiency [15][20] Product and Channel Strategy - The core product, Camellia Oil, has seen substantial revenue growth, contributing 46% of total revenue in the first half of 2025, with a remarkable growth rate of 176% [39] - The company has a balanced online and offline channel strategy, with online sales accounting for 65% of total revenue in the first half of 2025, reflecting a 137% growth [18][47] Brand Positioning and Customer Base - Lin Qingxuan has over 5.6 million active customers, with an average annual repurchase rate of 33.5%, indicating strong brand loyalty [30] - The brand is actively expanding its customer base, targeting younger consumers aged 18 to 24 through affordable yet effective skincare solutions [34] Future Growth Plans - The company plans to use the funds raised from the IPO to enhance brand marketing, upgrade supply chain capabilities, and explore overseas markets, aiming for sustainable growth and brand diversification [62][64]

Core Viewpoint - Lin Qingxuan is set to go public on the Hong Kong stock market after successfully submitting its prospectus following the listing hearing, aiming to become the first high-end domestic skincare stock and the first domestic essence oil stock in China [2][17]. Financial Performance - Lin Qingxuan's revenue has significantly increased from 691.5 million RMB in 2022 to 1.209641 billion RMB in 2024, with a notable 98.3% year-on-year growth in the first half of 2025, marking its first half-year revenue exceeding 1 billion RMB [3][18]. - The company turned a profit in 2023 with a net profit of 85 million RMB, which further increased to 187 million RMB in 2024, and reached 182 million RMB in the first half of 2025, with net profit margins improving to 10.5%, 15.4%, and 17.3% respectively [4][19]. Product Structure - The core product category for Lin Qingxuan is essence oil, generating revenues of 448 million RMB in 2024 and 478 million RMB in the first half of 2025, accounting for 37% and 45.5% of total revenue respectively [5][20]. - Lin Qingxuan's camellia oil essence has ranked first in retail sales among all facial essence oil products in China for 11 consecutive years since 2014, with cumulative sales exceeding 45 million bottles by June 30, 2025 [7][22]. Sales Channels - Online sales have seen a substantial increase, with revenue rising from 312 million RMB in 2022 to 714 million RMB in 2024, achieving a compound annual growth rate of 51.2%. By the first half of 2025, online revenue reached 688 million RMB, making up 65.4% of total sales [8][23]. - Offline revenue also grew from 378 million RMB in 2022 to 494 million RMB in 2024, with a compound annual growth rate of 14.3%. As of June 30, 2025, Lin Qingxuan operated 554 stores, primarily located in shopping malls [10][25]. Market Position - Lin Qingxuan is positioned as the leading high-end domestic skincare brand in China by retail sales in 2024, and it is part of a broader trend of domestic beauty brands seeking to list in Hong Kong to enhance their capital structure and global competitiveness [11][26]. - The company is among several domestic beauty brands, including Pechoin and Marubi, that have initiated their listing processes in Hong Kong, reflecting a new phase of capitalized development in the industry [14][29].

Core Insights - Lin Qingxuan has successfully passed the Hong Kong Stock Exchange hearing and is set to become the first high-end domestic skincare stock listed on the main board [1] - The company has shown strong revenue growth, with total revenue projected to increase from 691 million yuan in 2022 to 1.21 billion yuan in 2024, representing a compound annual growth rate of 32.3% [1] - In the first half of this year, Lin Qingxuan achieved a revenue of 1.052 billion yuan, marking a year-on-year increase of 98.3% [1] Group 1: Market Position and Product Offerings - Lin Qingxuan has been the top-selling essence oil brand in China for 11 consecutive years, focusing on anti-wrinkle and firming skincare products [2] - The company pioneered the "oil-based skincare" concept in 2014 and has launched several successful products, including the Camellia Oil Essence, which has sold over 45 million bottles [2] - The product lineup includes various recognized items that cater to diverse consumer skincare needs, such as brightening creams and anti-wrinkle serums [2] Group 2: Sales Channels and Customer Engagement - Lin Qingxuan has effectively integrated online and offline sales channels, with a total of 554 stores nationwide, over 95% of which are located in shopping malls [2] - The company has achieved significant online sales success, ranking first in multiple categories on platforms like Tmall during major shopping events [3] - Lin Qingxuan has over 5.6 million active customers, with an average annual repurchase rate of approximately 33.5%, outperforming the industry average [3] Group 3: Research and Development - The company holds 87 patents, including 46 invention patents, covering key areas such as formula development and extraction technology [4] - Lin Qingxuan has established a complete value chain for its core ingredients, ensuring quality and uniqueness in its products [4] - The company has secured long-term supply agreements with nine high-quality camellia flower planting bases, ensuring a stable supply of raw materials [5] Group 4: Industry Trends and Future Outlook - The demand for high-end skincare products in China is steadily increasing, with a notable surge in demand for quality and effective products [6] - Lin Qingxuan is positioned to redefine high-end domestic skincare through its innovative approaches and comprehensive sales strategies [6] - The upcoming listing on the capital market is expected to enhance the brand's influence and drive further innovation in the domestic skincare sector [6]

Core Viewpoint - Lin Qingxuan is set to become the first domestic high-end skincare brand to go public in Hong Kong, highlighting its significant growth and market position in the industry [3][4]. Financial Performance - In the first half of this year, Lin Qingxuan's revenue surged by 98.3% to 1.052 billion yuan compared to 530 million yuan in the same period of 2024 [4]. - The adjusted net profit for the same period increased by 117.4% to 200 million yuan from 92 million yuan in 2024, nearly matching the total profit for the entire year of 2024 [4]. Market Position - By 2024, Lin Qingxuan ranks first among all domestic high-end skincare brands in China and is the only domestic brand among the top 15 high-end skincare brands, which includes both domestic and international brands [9]. - In the high-end anti-wrinkle and firming skincare segment, Lin Qingxuan is the leading domestic brand and ranks among the top 10 overall [9]. Product Development - Lin Qingxuan has established itself as the only company in China's facial oil market to achieve full value chain integration of its core ingredients, holding 87 patents, including 46 invention patents [7]. - The flagship product, Camellia Oil, has sold over 45 million bottles since its launch in 2014 and has consistently ranked first in total retail sales among all facial oil products in China for 11 consecutive years [5]. Supply Chain and Production - Lin Qingxuan has secured long-term supply agreements with nine high-quality camellia flower planting bases covering over 20,000 acres in Zhejiang and Jiangxi provinces [8]. - The company adheres to strict production processes that meet pharmaceutical-grade standards, ensuring high quality and reliability of its products [8]. Customer Engagement - Lin Qingxuan has over 5.6 million active customers, with an average annual repurchase rate of approximately 33.5%, which is higher than the industry average [9]. - The company has a strong online presence, with a compound annual growth rate of 51.2% in online revenue from 2022 to 2024, and a year-on-year growth rate of 137.2% in the first half of this year [12]. Expansion Plans - Lin Qingxuan plans to initiate a global expansion process, starting with the Southeast Asian market [13]. - The funds raised from the IPO will be primarily used for brand building, enhancing sales networks, strengthening production and supply chain capabilities, and digital transformation [13].

Core Insights - Lin Qingxuan has updated its prospectus for its IPO in Hong Kong, indicating a potential shift in the competitive landscape of domestic beauty brands in China [1] - The company has changed its name from "Shanghai Lin Qingxuan Biotechnology Co., Ltd." to "Shanghai Lin Qingxuan Cosmetics Group Co., Ltd." to reflect its strategic intent towards multi-brand and group operations [2][4] - The updated prospectus highlights a significant increase in revenue, with a 98.3% year-on-year growth in the first half of 2025, reaching 1.052 billion yuan [21][22] - Lin Qingxuan aims to expand its brand portfolio and enhance its market presence through internal incubation and strategic acquisitions [32][36] - The company plans to initiate international expansion starting with Southeast Asia, leveraging its unique plant resources and the concept of "Chinese beauty" [48] Company Name Change - The name change signifies a strategic shift towards a multi-brand and group-oriented operation [2][4] - The term "high-end" appears more frequently in the updated prospectus, indicating a continued focus on premium positioning [5] Financial Performance - Lin Qingxuan reported a revenue of 1.052 billion yuan in the first half of 2025, a substantial increase from 530 million yuan in the same period last year [21][22] - The company’s net profit for the same period was 182 million yuan, with a gross margin of 82.4% [22] - Historical revenue figures show a consistent upward trend, with revenues of 691 million yuan in 2022, 805 million yuan in 2023, and projected 1.21 billion yuan in 2024 [23] Shareholder Structure - The shareholder structure remains largely unchanged, with the founder holding a significant portion of shares [12][15] - Notably, a new investment from Shanghai Kaihui Chuangmei, an affiliate of L'Oréal, has been made, indicating increased interest from international beauty giants [18][20] Product and Brand Strategy - Lin Qingxuan's flagship product, the Camellia Oil, has been a major revenue driver, accounting for 45.5% of total revenue in the first half of 2025 [28][31] - The company is focusing on expanding its product matrix and has introduced new brands targeting different consumer segments [32][35] Retail and Distribution - As of June 30, 2025, Lin Qingxuan operates 554 stores, with over 95% located in high-end shopping malls [44] - The average repurchase rate has slightly decreased to 33.5%, while the active customer base has grown significantly [44] - Online sales accounted for 65.4% of total revenue in the first half of 2025, indicating a strong digital presence [48] Future Outlook - Lin Qingxuan plans to enhance its R&D capabilities, with an increase in the number of researchers to 85, focusing on developing proprietary ingredients and technologies [36][42] - The company is exploring potential acquisitions to strengthen its supply chain and expand its brand portfolio [36][40] - The upcoming IPO could position Lin Qingxuan as the leading domestic high-end skincare brand in the Hong Kong market, potentially altering the competitive dynamics within the industry [11][48]

Core Viewpoint - Shanghai Linqingxuan Cosmetics Group Co., Ltd. is advancing its IPO process on the Hong Kong Stock Exchange, aiming to become the "first high-end domestic skincare stock" in Hong Kong, with significant revenue and profit growth reported in the first half of the year [3][4]. Company Overview - Founded in 2003, Linqingxuan focuses on high-end domestic skincare products, particularly anti-wrinkle and firming products, with its flagship product being the Camellia Oil [5]. - The Camellia Oil has sold over 45 million bottles since its launch in 2014 and has consistently ranked first in retail sales among facial oils in China for 11 consecutive years [5][8]. Financial Performance - In the first half of this year, Linqingxuan's revenue surged by 98.3% to 1.052 billion yuan compared to the same period in 2024 [3]. - The adjusted net profit for the same period increased by 117.4% to 200 million yuan, nearly matching the total profit for the entire year of 2024 [4]. Product Development - Linqingxuan has developed a range of proprietary ingredients and products centered around Camellia, including various patented components that target specific skincare needs [7]. - As of June 30, 2025, the company offers 230 SKUs, including serums, creams, toners, and sunscreens, catering to diverse customer skincare needs [8]. Market Position - Linqingxuan ranks first among domestic high-end skincare brands in China and is the only domestic brand among the top 15 high-end skincare brands, including international brands [8]. - In the anti-wrinkle and firming segment, Linqingxuan is also the leading domestic brand and ranks among the top 10 overall [8]. Customer Engagement - The company has over 5.6 million active customers, with an average annual repurchase rate of approximately 33.5%, exceeding the industry average [9]. Distribution Channels - As of June 30, 2025, Linqingxuan operates 554 stores, primarily located in shopping malls, ranking first among domestic and international high-end skincare brands in terms of store count [11]. - The company has a strong online presence, with a compound annual growth rate of 51.2% in online revenue from 2022 to 2024, and a remarkable 137.2% year-on-year growth in the first half of this year [12]. Future Plans - Linqingxuan plans to initiate a global expansion strategy, starting with the Southeast Asian market [13]. - The funds raised from the IPO will be used for brand development, sales network enhancement, production capacity improvement, and digital infrastructure upgrades [14].

Investment Rating - The report does not explicitly state an investment rating for the company Core Insights - The company is a leader in the high-end domestic skincare market in China, focusing on anti-wrinkle and firming skincare products, with its flagship brand "Lin Qing Xuan" offering high-end skincare solutions based on natural camellia ingredients [3][8] - The market for skincare products in China is projected to reach CNY 688.6 billion by 2024, with a compound annual growth rate (CAGR) of 6.8% from 2019 to 2024, and an expected CAGR of 8.6% from 2024 to 2029 [4][37] - The facial essence oil category, driven by the "oil-based skincare" trend, is expected to grow significantly, with a market size of CNY 5.3 billion in 2024 and a CAGR of 42.8% from 2019 to 2024 [4][37] - The company has seen substantial revenue growth, with a projected revenue of CNY 1.21 billion in 2024, representing a 50.3% year-on-year increase [18] Company Overview - The company has established itself as a rare high-end domestic skincare brand, with its camellia essence oil being the top-selling product in the facial essence oil category for 11 consecutive years [3][8] - The company has a balanced distribution of online and offline channels, with online sales growing significantly, contributing to overall revenue growth [5][25] - The company has a strong presence in the high-end anti-wrinkle skincare market, ranking first among domestic brands and being the only domestic brand in the top ten [3][8] Market Trends - The demand for anti-wrinkle and firming skincare products is high, with a projected market size of CNY 119.8 billion in 2024 and a CAGR of 15.0% from 2019 to 2024 [49] - The high-end skincare segment is expected to grow faster than the mass market, with a projected CAGR of 8.9% from 2019 to 2024 [43] Financial Performance - The company's gross margin has been consistently high, with projections of 82.5% in 2024, and a significant improvement in net profit margin from -0.9% in 2022 to 15.4% in 2024 [88] - The company has achieved a turnaround in profitability, with a net profit of CNY 187 million in 2024, representing a 121.1% year-on-year increase [18][88] Distribution Channels - The company has expanded its offline presence, with a total of 506 stores by the end of 2024, primarily located in shopping malls [78] - Online sales have become the dominant revenue source, accounting for 59.1% of total revenue in 2024, with significant growth in both direct sales and sales through online retailers [25][74] Product Strategy - The company's primary product category is facial essence oil, which has seen a revenue increase from CNY 218 million in 2022 to CNY 448 million in 2024, with a growing market share [66][70] - The company has successfully positioned its camellia essence oil as a leading product in the market, with cumulative sales exceeding 30 million bottles by the end of 2024 [66]

Core Insights - Lin Qingxuan, a beauty company, has positioned itself in the high-end skincare market with its flagship product, Camellia Oil, which has a gross margin of 82.5% [1][6] - The company has shown significant revenue growth, with sales increasing from 691 million yuan in 2022 to 1.21 billion yuan in 2024, representing a compound annual growth rate (CAGR) of 32.3% [1][5] - Lin Qingxuan plans to use the funds raised from its Hong Kong IPO to enhance brand value, expand sales channels, and improve production and supply chain capabilities [1] Revenue and Product Performance - The Camellia Oil product line has contributed over 30% of the company's revenue, with sales reaching 218 million yuan in 2022, 284 million yuan in 2023, and 448 million yuan in 2024 [3][5] - The market for facial oils in China is rapidly growing, with a projected increase from 900 million yuan in 2019 to 5.3 billion yuan in 2024, achieving a CAGR of 42.8% [2] - Lin Qingxuan's product strategy includes continuous upgrades to its core products and the introduction of new SKUs, resulting in a diverse product offering of 188 SKUs by the end of 2024 [3][6] Sales Channels and Market Strategy - The company has expanded its sales channels, with nearly 60% of its revenue coming from online sales by 2024, up from 45.2% in 2022 [9][10] - Lin Qingxuan has focused on offline expansion, with over 95% of its 506 stores located in high-end shopping malls, contributing significantly to its revenue [8] - The company has successfully leveraged live-streaming e-commerce, with its founder participating in live broadcasts to boost online sales [10] Investment and Valuation - Lin Qingxuan has attracted notable investors, including YOUNGOR and various venture capital firms, indicating strong market interest [11][12] - The company's valuation before its IPO is estimated to be around 3.84 billion yuan, based on recent equity transactions [12][13] - Compared to other publicly listed beauty companies, Lin Qingxuan's revenue is relatively smaller, with 1.21 billion yuan in 2024, highlighting the challenges it may face in meeting IPO valuation expectations [14]

Core Viewpoint - The article discusses the IPO of Shanghai Linqingxuan Biotechnology Co., Ltd., highlighting its high-end positioning in the skincare market and the success of its flagship product, Camellia Oil, which has achieved significant sales and profitability growth since its launch [1][2][3]. Group 1: Company Overview - Linqingxuan was founded in 2003, launching its flagship brand in 2004 and opening its first store in 2008. The company officially introduced its core product, Camellia Oil, in 2014, targeting the facial oil segment [4]. - The market for facial oils in China has grown from 900 million yuan in 2019 to an expected 5.3 billion yuan by 2024, with a compound annual growth rate (CAGR) of 42.8% [4]. Group 2: Financial Performance - Revenue increased from 691 million yuan in 2022 to 805 million yuan in 2023, and is projected to reach 1.21 billion yuan in 2024, with a CAGR of 32.3% [7]. - The company turned a profit from a loss of 5.93 million yuan in 2022 to a net profit of 85 million yuan in 2023, and further to 187 million yuan in 2024 [8]. - Gross margins have improved from 78.0% in 2022 to 82.5% in 2024 [9]. Group 3: Product Strategy - The company focuses on a single flagship product, Camellia Oil, which has maintained the top position in the facial oil market for 11 consecutive years and is the only product in this category to exceed 100 million yuan in retail sales for eight years [6]. - The product pricing strategy ranges from 200 yuan to 800 yuan, with premium products priced as high as 1,880 yuan for a 50ml cream [5]. Group 4: Marketing and Sales Channels - Linqingxuan has invested 760 million yuan in marketing over three years, although it faced penalties for false advertising [11][13]. - The company has expanded its retail presence to 506 stores by the end of 2024, with over 95% located in shopping malls [18]. - Online sales have surged, with revenue from online channels increasing from 312 million yuan in 2022 to 714 million yuan in 2024, surpassing offline sales for the first time [20]. Group 5: Investment and Valuation - The company has attracted significant investment from notable firms, completing multiple funding rounds and achieving a pre-IPO valuation of approximately 3.84 billion yuan [26]. - Comparatively, Linqingxuan's revenue of 1.21 billion yuan in 2024 is smaller than that of other listed beauty companies, raising questions about its ability to meet IPO valuation expectations [27].